Myriad Genetics (MYGN) Shareholder's Equity Growth (1y) (2011 - 2026)
Myriad Genetics (MYGN) Shareholder's Equity Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.14% |
| Dec 31, 2025 | -47.51% |
| Sep 30, 2025 | -49.05% |
| Jun 30, 2025 | -47.59% |
| Mar 31, 2025 | -7.25% |
| Dec 31, 2024 | -10.48% |
| Sep 30, 2024 | 7.07% |
| Jun 30, 2024 | 0.72% |
| Mar 31, 2024 | -9.00% |
| Dec 31, 2023 | -11.58% |
| Sep 30, 2023 | -25.44% |
| Jun 30, 2023 | -22.40% |
| Mar 31, 2023 | -12.09% |
| Dec 31, 2022 | -8.47% |
| Sep 30, 2022 | -5.36% |
| Jun 30, 2022 | 4.99% |
| Mar 31, 2022 | 8.56% |
| Dec 31, 2021 | 9.85% |
| Sep 30, 2021 | 6.51% |
| Jun 30, 2021 | -1.72% |